Picture Demy-Colton BioFuture 2023 NYC Hand 650x100px

Document › Details

Waters Corporation. (6/22/17). "Press Release: Waters Corporation Elects Flemming Ornskov to Board of Directors". Milford, MA.

	Organisation	Waters Corporation (NYSE: WAT)
	Group	Waters (Group)
	Product	analytical instrument
	Product 2	pharmaceutical
	Person	O’Connell, Christopher J. (Chris) (Waters 201509–202009 CEO before over 21 years at Medtronic)

Waters Corporation (NYSE: WAT) today announced Dr. Flemming Ornskov, Chief Executive Officer of Shire plc, has been elected as a Director of Waters® Corporation effective today.

"It is an honor to welcome Flemming Ornskov to our Board of Directors," said Christopher J. O'Connell, Waters Corporation President and CEO. "Flemming's broad, global leadership experience in the biopharmaceutical industry will add great value to Waters' strategic and governance processes. Moreover, Flemming's strong character and passion for human health make him a great addition to Waters' values-oriented culture."

“I have been impressed with the Waters Corporation’s support for researchers and organizations whose innovative work helps heal, feed and protect people around the world,” said Shire’s Flemming Ornskov, M.D., M.P.H. “I look forward to working with Chris and the entire Board in pursuing a bright future for the Company, its employees and those they serve.”

Dr. Ornskov was appointed Chief Executive Officer of Shire plc in April, 2013, where he serves as Chairman of the Executive Committee, and is a member of the Board of Directors. Dr. Ornskov brings broad operational and medical knowledge, and extensive international, strategic and operational experience in the pharmaceutical sector. Prior to Shire, Dr. Ornskov held key executive leadership positions at Bayer, Bausch & Lomb, Inc., Merck & Co., Inc. and Novartis AG. Dr. Ornskov received his MD from the University of Copenhagen, his MBA from INSEAD, and his Master of Public Health from Harvard University. Before his business career, Dr. Ornskov, trained as an intern and resident in pediatrics at the University Hospital of Copenhagen.

About Waters Corporation (www.waters.com)

Waters Corporation (NYSE: WAT), the world's leading specialty measurement company, has pioneered chromatography, mass spectrometry and thermal analysis innovations serving the life, materials and food sciences for nearly 60 years. With approximately 7,000 employees worldwide, Waters operates directly in 27 countries, including 11 manufacturing facilities, and with products available in more than 100 countries.

Waters is a registered trademark of the Waters Corporation.

Waters Corporation

John Lynch, 508-482-2314
Investor Relations
John_Lynch@waters.com
or
Jeff Tarmy, 508-482-2268
Corporate Communications
Jeff_Tarmy@waters.com

Record changed: 2023-06-05